Sensorion Receives French Regulatory Approval to Begin SENS-601 Gene Therapy Trial for GJB2 Hearing Loss
MONTPELLIER, FRANCE ā Sensorion, a pioneering biotechnology company focused on gene therapies for inner ear disorders, has achieved a critical regulatory milestone with the…
